The same technology that was used in the covid jabs will soon be used in influenza vaccines.
The Phase 3 trial of an mRNA flu vaccine has already started at two major big pharma companies, Moderna and Pfizer.
Dr Robert Malone who helped invest the mRNA technology used in the Covid jabs has been urging the public not to have them as they could permanently damage the critical organs, reproductive systems, and immune systems, or may even cause death.
Malone, the Chief Medical and Regulatory Officer for The Unity Project who invented messenger mRNA therapeutics in 1988, says the public is being misled about the vaccine’s efficacy and effects.
The Gateway Pundit reports: A major Phase 3 clinical trial assessing the efficacy, safety, tolerability, and immunogenicity of Pfizer’s quadrivalent modified RNA (modRNA) influenza vaccine candidate in about 25,000 healthy U.S. adults has begun dosing participants, the pharmaceutical giant reported last month.
“For years, there has been a need to better address the burden of influenza, despite the use of existing seasonal flu vaccines. Our experience with RNA viruses and mRNA technology has given us an even deeper understanding of the opportunity to potentially provide more efficacious vaccines that could further reduce the yearly rates of the severe outcomes of viral disease like flu, including hospitalization and death,” claimed Annaliesa Anderson, Ph.D., Senior Vice President and Chief Scientific Officer, Vaccine Research and Development, Pfizer.
“We are excited to start the first Phase 3 efficacy study of an mRNA-based influenza vaccine that could potentially deliver an improved flu vaccine to help address the significant burden of this disease,” she added.
Pfizer ensures that its clinical trial participants properly represent the racial and ethnic diversity of the countries in which they are conducted.
“The impact of flu on racial and ethnic minority groups in the U.S. is even larger. Black Americans are 1.8 times more likely than their white counterparts to be hospitalized for flu while Latino and Indigenous Americans are 1.2 and 1.3 times more likely, respectively,” according to the news release.
This study is enrolling people who:
Leave a Reply